The Global Wire
MarketsSports
MARKETS16:43 UTC1d ago 1 min readSource: Investing.com

Jefferies raises Allogene stock price target to $10 on trial data

Share
Jefferies raises Allogene stock price target to $10 on trial data
Image via Investing.com

Read Full Report at Investing.com
AI Executive Brief
  • / Jefferies, a financial services company, has increased its price target for Allogene stock to $10.
  • / The increase is based on positive data from Allogene's clinical trials.
  • / This development is likely to attract investor interest in Allogene.

AI-generated summary for informational purposes. Verify with original source.

More from The Global Wire

Citizens Financial: Solid Q1 Shows No Signs Of Economic Weakness
MARKETS7h ago

Citizens Financial: Solid Q1 Shows No Signs Of Economic Weakness

Zonda exchange says 4.5K BTC wallet inaccessible amid withdrawal crisis
MARKETS7h ago

Zonda exchange says 4.5K BTC wallet inaccessible amid withdrawal crisis

Retail traders pile into Allbirds after odd AI pivot. History shows it won't end well
MARKETS7h ago

Retail traders pile into Allbirds after odd AI pivot. History shows it won't end well

Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance
MARKETS7h ago

Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance

General Mills announces €1.7 billion notes offering due 2056
MARKETS7h ago

General Mills announces €1.7 billion notes offering due 2056

First Horizon: A Decent Start, But Follow Through Is Key
MARKETS7h ago

First Horizon: A Decent Start, But Follow Through Is Key

Stay ahead of every story

The Global Wire — Live Front Page

Real-time AI-powered news from 55+ sources. Breaking stories, market signals, sports, geopolitics — all in one place.

Explore The Global Wire

Free • No login required • Updated every 15 minutes